As global markets experience volatility, with technology stocks facing pressure and cyclical sectors gaining traction, investors are increasingly attentive to growth opportunities in Asia's dynamic economic landscape. In this environment, companies with high insider ownership can be particularly appealing as they often reflect strong confidence from those who know the business best, making them potential standouts amid shifting market conditions.
Top 10 Growth Companies With High Insider Ownership In Asia
| Name |
Insider Ownership |
Earnings Growth |
|---|---|---|
| UTI (KOSDAQ:A179900) |
24.7% |
120.7% |
| Suzhou Dongshan Precision Manufacturing (SZSE:002384) |
26.5% |
74.1% |
| Seers Technology (KOSDAQ:A458870) |
32% |
80% |
| Novoray (SHSE:688300) |
23.6% |
31.4% |
| Modetour Network (KOSDAQ:A080160) |
12.3% |
41.8% |
| Loadstar Capital K.K (TSE:3482) |
31% |
23.6% |
| Laopu Gold (SEHK:6181) |
34.7% |
34.7% |
| HUMAN MADE (TSE:456A) |
12.3% |
22.8% |
| Guangzhou Tinci Materials Technology (SZSE:002709) |
39.1% |
83.3% |
| Fulin Precision (SZSE:300432) |
10.6% |
80% |
Let's uncover some gems from our specialized screener.
Deepexi Technology
Simply Wall St Growth Rating:★★★★★★
Overview:Deepexi Technology Co., Ltd. offers enterprise-level big-model AI application solutions in China and has a market cap of HK$29.71 billion.
Operations:The company's revenue segment includes the sale of FastData and FastAGI solutions, generating CN¥314.53 million.
Insider Ownership:21.9%
Revenue Growth Forecast:67.2% p.a.
Deepexi Technology is poised for significant growth with expected annual revenue increases of 67.2%, outpacing the Hong Kong market. Despite negative shareholders' equity, its forecasted profitability and high return on equity in three years highlight potential upside. Recent strategic cooperation with MetaX Integrated Circuits aims to enhance AI applications across key industries, leveraging combined strengths for comprehensive solutions. This partnership underscores Deepexi's commitment to innovation and expansion in digital intelligence sectors without recent insider trading activity affecting sentiment.
Chifeng Jilong Gold MiningLtd
Simply Wall St Growth Rating:★★★★☆☆
Overview:Chifeng Jilong Gold Mining Co., Ltd. is involved in the mining, metallurgical processing, and sales of gold on a global scale, with a market cap of CN¥70.86 billion.
Operations:Chifeng Jilong Gold Mining Co., Ltd. generates revenue through its global operations in gold extraction, processing, and sales.
Insider Ownership:14.1%
Revenue Growth Forecast:16.4% p.a.
Chifeng Jilong Gold Mining Ltd. is experiencing substantial growth, with earnings expected to increase significantly over the next three years. The company's recent guidance forecasts a net profit rise of 70% to 81% for 2025, driven by increased gold production and higher selling prices. Despite high share price volatility, it trades at a significant discount to its estimated fair value and offers good relative value compared to peers in the industry.
-
Take a closer look at Chifeng Jilong Gold MiningLtd's potential here in our earnings growth report.
-
Our valuation report here indicates Chifeng Jilong Gold MiningLtd may be undervalued.
Hubei Zhenhua ChemicalLtd
Simply Wall St Growth Rating:★★★★☆☆
Overview:Hubei Zhenhua Chemical Co., Ltd. is involved in the research, development, manufacture, and sale of chromium salt and related products mainly in China, with a market cap of CN¥26.41 billion.
Operations:The company's revenue primarily comes from the production and sale of chromium salt and related products within China.
Insider Ownership:39.4%
Revenue Growth Forecast:20.1% p.a.
Hubei Zhenhua Chemical Ltd. is poised for growth, with earnings projected to increase by 25.88% annually, although this is slightly below the broader CN market's growth rate. Revenue growth outpaces the market at 20.1% per year, signaling robust expansion potential despite a forecasted low return on equity of 19.1%. The stock has shown high volatility recently and no significant insider trading activity was reported in the past three months.
Next Steps
-
Investigate our full lineup of 578 Fast Growing Asian Companies With High Insider Ownership right here.
-
Want To Explore Some Alternatives? AI is about to change healthcare. These 106 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include SEHK:1384 SHSE:600988 and SHSE:603067.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
